NIH Funding · FY2024
Total Funding
$865.3K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#17,630
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $865.3K across 1 grant · National rank #17630.
Top grants by award amount
Mark B Geyer's NIH grant portfolio, ranked by award amount.
- 5R42CA254685-03R42Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL$865.3Kaward amount
Affiliation
Institutions that have administered grants for Mark B Geyer.
Affiliated with Actinium Pharmaceuticals, Inc. (NY).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardActinium Pharmaceuticals, Inc.
- 2024$500K Cumulative Funding
Related investigators
Other NIH-funded PIs frequently associated with Mark B Geyer.
Explore further
Find collaborators for Mark B Geyer
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Actinium Pharmaceuticals, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →